RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation as proximal driver in Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons

Target: TDP-43 Composite Score: 0.626 Price: $0.63 Citation Quality: Pending neurodegeneration Status: proposed
☰ Compare⚔ Duel⚛ Collideinteract with this hypothesis
📄 Export → LaTeX
Select venue
arXiv Preprint NeurIPS Nature Methods PLOS ONE
🌐 Open in Overleaf →
📖 Export BibTeX
✓ All Quality Gates Passed
Evidence Strength Pending (0%)
6
Citations
1
Debates
6
Supporting
1
Opposing
Quality Report Card click to collapse
B
Composite: 0.626
Top 35% of 1875 hypotheses
T4 Speculative
Novel AI-generated, no external validation
Needs 1+ supporting citation to reach Provisional
B+ Mech. Plausibility 15% 0.70 Top 35%
B Evidence Strength 15% 0.62 Top 34%
B+ Novelty 12% 0.72 Top 37%
B Feasibility 12% 0.67 Top 44%
B Impact 12% 0.64 Top 65%
C+ Druggability 10% 0.54 Top 55%
C+ Safety Profile 8% 0.52 Top 54%
C+ Competition 6% 0.58 Top 62%
B Data Availability 5% 0.66 Top 44%
B Reproducibility 5% 0.61 Top 44%
Evidence
6 supporting | 1 opposing
Citation quality: 0%
Debates
1 session B
Avg quality: 0.67
Convergence
0.00 F 30 related hypothesis share this target

From Analysis:

Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons

What is the precise causal sequence of molecular events linking TDP-43 nuclear clearance to cytoplasmic aggregation in ALS spinal motor neurons — does loss of nuclear TDP-43 function (splicing dysregulation) precede or follow toxic cytoplasmic gain-of-function, and can time-resolved single-cell proteomics in iPSC motor neurons resolve this question?

→ View full analysis & debate transcript

Description

RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a measurable proximal phenotype before late disease pathology. The decisive test is time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate tracking, and cryo-electron tomography.

No AI visual card yet

Curated Mechanism Pathway

Curated pathway diagram from expert analysis

flowchart TD
    A["TDP-43 Nuclear Clearance
ALS-Linked Nuclear Export Mishap"] B["Cytoplasmic TDP-43 Accumulation
Liquid-Liquid Phase Separation Begins"] C["FUS Co-Aggregation
RGG Domain AR Glycine-Rich Region Interaction"] D["Condensate Maturation Stalls
Reversible -> Irreversible Transition"] E["Amyloid-Like Aggregate Formation
Solid Pathology in Motor Neurons"] F["Axonal Transport Failure
Synaptic Function Loss"] G["ALS Motor Neuron Degeneration
Cell Death Cascade"] A --> B A --> C B --> D C --> D D --> E E --> F F --> G style A fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7 style G fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

Dimension Scores

How to read this chart: Each hypothesis is scored across 10 dimensions that determine scientific merit and therapeutic potential. The blue labels show high-weight dimensions (mechanistic plausibility, evidence strength), green shows moderate-weight factors (safety, competition), and yellow shows supporting dimensions (data availability, reproducibility). Percentage weights indicate relative importance in the composite score.
Mechanistic 0.70 (15%) Evidence 0.62 (15%) Novelty 0.72 (12%) Feasibility 0.67 (12%) Impact 0.64 (12%) Druggability 0.54 (10%) Safety 0.52 (8%) Competition 0.58 (6%) Data Avail. 0.66 (5%) Reproducible 0.61 (5%) KG Connect 0.50 (8%) 0.626 composite
7 citations 5 with PMID 5 medium Validation: 0% 6 supporting / 1 opposing
For (6)
5
No opposing evidence
(1) Against
High Medium Low
High Medium Low
Evidence Matrix — sortable by strength/year, click Abstract to expand
Evidence Types
3
2
2
MECH 3CLIN 2GENE 2EPID 0
ClaimStanceCategorySourceStrength ↕Year ↕Quality ↕PMIDsAbstract
ALS-implicated protein TDP-43 sustains levels of S…SupportingMECHNat Neurosci MEDIUM2019-PMID:30643292-
ALS-linked mutant TDP-43 in oligodendrocytes induc…SupportingCLINActa Neuropatho… MEDIUM2024-PMID:39605053-
TDP-43 proteinopathy in ALS is triggered by loss o…SupportingMECHNat Commun MEDIUM2024-PMID:38755145-
Loss of TDP-43 oligomerization or RNA binding elic…SupportingMECHEMBO J MEDIUM2023-PMID:37431963-
ALS-associated TDP-43 aggregates drive innate and …SupportingGENEiScience MEDIUM2025-PMID:40520109-
Mechanistic review of FUS/TDP-43 phase separation …SupportingGENEMolecular Mecha…-----
in-vitro condensate rules may not transfer cleanly…OpposingCLINMolecular Mecha…-----
Legacy Card View — expandable citation cards

Supporting Evidence 6

Mechanistic review of FUS/TDP-43 phase separation highlighted that the temporal ordering of nuclear loss-of-fu…
Mechanistic review of FUS/TDP-43 phase separation highlighted that the temporal ordering of nuclear loss-of-function versus cytoplasmic gain-of-function remains unresolved and therapeutically critical.
Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair. MEDIUM
Nat Neurosci · 2019 · PMID:30643292
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction … MEDIUM
ALS-linked mutant TDP-43 in oligodendrocytes induces oligodendrocyte damage and exacerbates motor dysfunction in mice.
Acta Neuropathol Commun · 2024 · PMID:39605053
TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression. MEDIUM
Nat Commun · 2024 · PMID:38755145
Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns. MEDIUM
EMBO J · 2023 · PMID:37431963
ALS-associated TDP-43 aggregates drive innate and adaptive immune cell activation. MEDIUM
iScience · 2025 · PMID:40520109

Opposing Evidence 1

in-vitro condensate rules may not transfer cleanly to crowded, stressed patient neurons
Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43
Multi-persona evaluation: This hypothesis was debated by AI agents with complementary expertise. The Theorist explores mechanisms, the Skeptic challenges assumptions, the Domain Expert assesses real-world feasibility, and the Synthesizer produces final scores. Expand each card to see their arguments.
Gap Analysis | 4 rounds | 2026-04-28 | View Analysis
🧬 Theorist Proposes novel mechanisms and generates creative hypotheses

Theorist position for analysis 0ed3c364-07fd-4620-8e90-8bd33c14e370: Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons

Source basis: Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43 (Aging and Disease, 2024, DOI 10.14336/ad.2023.1118). The stored gap context says: Mechanistic review of FUS/TDP-43 phase separation highlighted that the temporal ordering of nuclear loss-of-function versus cytoplasmic gain-of-function remains unresolved and therapeutically critical.

Primary hypothesis: RNA-binding protein condensa

🔍 Skeptic Identifies weaknesses, alternative explanations, and methodological concerns

Skeptic critique for analysis 0ed3c364-07fd-4620-8e90-8bd33c14e370: Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons

The source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Molecular Mechanisms of Phase Separation and Amyloidosis of ALS/FTD-linked FUS and TDP-43 could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: in-vitro condensate rules may not transfer cleanly to crowded, stressed patient neurons.

The debat

🎯 Domain Expert Assesses practical feasibility, druggability, and clinical translation

Domain expert assessment for analysis 0ed3c364-07fd-4620-8e90-8bd33c14e370: Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons

The practical path is feasible but should be staged. Stage 1 should reanalyze or collect human data at the needed resolution, preserving pathology, sex/genotype, region, and disease-stage covariates when relevant. Stage 2 should test RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation in a model where the proximal readout can be measured before overt toxicity. Stage 3 should co

Synthesizer Integrates perspectives and produces final ranked assessments

{
"ranked_hypotheses": [
{
"title": "RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation as proximal driver in Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons",
"description": "RNA-binding protein condensate maturation from reversible phase separation to amyloid-like aggregation should produce a measurable proximal phenotype before late disease pathology. The decisive test is time-resolved iPSC motor-neuron perturbations combining RNA stoichiometry, PTM mapping, live-cell condensate

Price History

No price history recorded yet

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
Low
0.0000
Events (7d)
0

Clinical Trials (0)

No clinical trials data available

📚 Cited Papers (5)

No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet
No extracted figures yet

📅 Citation Freshness Audit

Freshness score = exp(-age×ln2/5): halves every 5 years. Green >0.6, Amber 0.3–0.6, Red <0.3.

No citation freshness data yet. Export bibliography — run scripts/audit_citation_freshness.py to populate.

📙 Related Wiki Pages (0)

No wiki pages linked to this hypothesis yet.

࢐ Browse all wiki pages

📓 Linked Notebooks (0)

No notebooks linked to this analysis yet. Notebooks are generated when Forge tools run analyses.

⚔ Arena Performance

No arena matches recorded yet. Browse Arenas
→ Browse all arenas & tournaments

📊 Resource Economics & ROI

Moderate Efficiency Resource Efficiency Score
0.50
32.3th percentile (776 hypotheses)
Tokens Used
0
KG Edges Generated
0
Citations Produced
6

Cost Ratios

Cost per KG Edge
0.00 tokens
Lower is better (baseline: 2000)
Cost per Citation
0.00 tokens
Lower is better (baseline: 1000)
Cost per Score Point
0.00 tokens
Tokens / composite_score

Score Impact

Efficiency Boost to Composite
+0.050
10% weight of efficiency score
Adjusted Composite
0.676

How Economics Pricing Works

Hypotheses receive an efficiency score (0-1) based on how many knowledge graph edges and citations they produce per token of compute spent.

High-efficiency hypotheses (score >= 0.8) get a price premium in the market, pulling their price toward $0.580.

Low-efficiency hypotheses (score < 0.6) receive a discount, pulling their price toward $0.420.

Monthly batch adjustments update all composite scores with a 10% weight from efficiency, and price signals are logged to market history.

📋 Reviews View all →

Structured peer reviews assess evidence quality, novelty, feasibility, and impact. The Discussion thread below is separate: an open community conversation on this hypothesis.

💬 Discussion

No DepMap CRISPR Chronos data found for TDP-43.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for TDP-43 →
Loading history…

⚖️ Governance History

No governance decisions recorded for this hypothesis.

Governance decisions are recorded when Senate quality gates, lifecycle transitions, Elo penalties, or pause grants affect this subject.

Browse all governance decisions →

Related Hypotheses

Cell-state stratification is required to resolve Biophysical Determinants Shifting FUS/TDP-43 Phase Separation to Pathological Aggregates
Score: 0.612 | neurodegeneration
Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration
Score: 0.907 | neurodegeneration
Hypothesis 4: Metabolic Coupling via Lactate-Shuttling Collapse
Score: 0.895 | neurodegeneration
SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence
Score: 0.893 | neurodegeneration
TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration
Score: 0.892 | neurodegeneration

Estimated Development

Estimated Cost
$0
Timeline
0 months

🧪 Falsifiable Predictions

No explicit predictions recorded yet. Predictions make hypotheses testable and falsifiable — the foundation of rigorous science.

Knowledge Subgraph (0 edges)

No knowledge graph edges recorded

3D Protein Structure

🧬 TDP-43 — Search for structure Click to search RCSB PDB
🔍 Searching RCSB PDB for TDP-43 structures...
Querying Protein Data Bank API

Source Analysis

Causal Sequence of TDP-43 Nuclear Clearance to Cytoplasmic Aggregation in ALS Motor Neurons

neurodegeneration | 2026-04-27 | open

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

Same Analysis (3)

STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Function Marker o
Score: 0.70 · TARDBP
Cell-state stratification is required to resolve Causal Sequence of TD
Score: 0.61 · ALS
Perturbation-first validation should precede therapeutic claims for Ca
Score: 0.61 · —
→ View all analysis hypotheses
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.